<DOC>
	<DOCNO>NCT01475747</DOCNO>
	<brief_summary>Systolic Pressure Intervention Trial ( SPRINT ) large scale randomize trial ~ 9250 adult age 50 year old high cardiovascular risk sponsor NIH . The study design recruit 45 % study population Chronic Kidney Disease ( CKD ) . The trial test effect low systolic blood pressure ( SBP ) goal &lt; 120 mm Hg versus standard goal &lt; 140 mm Hg primary composite cardiovascular event death . One pre-specified secondary outcome progression kidney disease . In ancillary name SPRINT - Factors affect Atherosclerosis STudy ( FAST ) , investigator plan take advantage unique opportunity afford parent study examine issue significant public health importance . This observational study SPRINT participant . This study examine mechanistically , factor affect progression atherosclerosis CKD .</brief_summary>
	<brief_title>Systolic Pressure Intervention Trial Factors Affecting Factors Affecting Atherosclerosis Study</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<criteria>Inclusion Criteria Systolic Pressure Intervention Trial ( SPRINT ) participant Exclusion Criteria Contraindications MRI ( intracranial metal prosthesis , weight &gt; 300 pound , claustrophobia certain type hardware use pacemaker , prosthesis , etc . )</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>